The splice mutation PMS2 c.989-1G > T met the InSiGHT criteria class 5 for pathogenicity[14]: mRNA analysis showed that it caused two abnormal transcripts, it co-segregates with disease, more than 2 tumours were MSI-high and has a population frequency <1%. The gene discussed is PMS2; the disease is neoplasm.